AtriCure, Inc. To Participate At The Third Annual JMP Securities Healthcare Focus Conference In October

WEST CHESTER, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems, today announced that David J. Drachman, President and Chief Executive Officer, is scheduled to present at the Third Annual JMP Securities Healthcare Focus Conference at Le Parker Meridien Hotel in New York City on October 6 at 9:30 a.m. Eastern Time.

MORE ON THIS TOPIC